Risk factors and outcomes of @entity5011 with acute XXXX .

@entity1 @entity32 @entity17 @entity1494 @entity425 @entity5011 @entity5433 @entity4685
@entity5011 and acute @entity4685 represent common and very rare etiologies of @entity425 in @entity1 , respectively. Typically, @entity17 is most common, limited to either the central or peripheral nervous system. Concurrent acute @entity4685 and @entity5011 are seldom reported. We retrospectively reviewed cases of @entity5011 in Chang Gung @entity1 's Hospital from 2000-2008. The risk factors of @entity5011 with or without acute @entity4685 were analyzed. Thirty-six @entity1 with @entity5011 were enrolled. Five @entity1 manifested coexisting acute @entity4685 . In the disease's earliest stage, differentiating concurrent acute @entity4685 and @entity5011 from @entity5011 only was difficult. Four of 5 @entity1 were aged more than 8 years. All @entity1 developed a sharply defined sensory level, and manifested severe @entity1494 . @entity5433 was evident in three @entity1 . All @entity1 with sufficient follow-up continued to demonstrate residual paresis, and two demonstrated significant long-term motor deficits. Detection of a sharply defined sensory level, severe @entity1494 , and @entity5433 can be helpful in recognizing concurrent acute @entity4685 . Therefore, recognition of this combination of peripheral and central nervous @entity32 early is important for determining prognoses and perhaps initial treatment.
